Development of Antibody Drugs Accelerating in the Field of Asthma; First New Option Could Be Available as Early as 2016

Drug makers are accelerating their development of antibody drugs in the field of asthma, where competition is intensifying due to the entry of inhaled corticosteroid (ICS) combination drugs and other products. The use of antibody drugs for asthma is restricted...read more